StockTipsArenaBeta

BUY Emcure Pharmaceuticals Limited — IDBI Capital

BUYEmcure Pharmaceuticals Limited
Emcure Pharmaceuticals share price target & all analyst calls

byIDBI CapitalHorizon: Intraday1 Oct 2026, 9:34 am ISTvia IDBI Capital Research Calls Telegram

Entry₹1,946Stated
Target₹1,996
Total upside +2.57% (call closed)
Stop loss₹1,921-1.28% risk
Exit₹1,921Stop-loss hit — time not yet verified
Stop-loss hit-1.28%
Follow IDBI Capital for new calls(5% target hit, 19 closed calls)Get alertsWatch EMCURE for new buy/sell callsGet alertsSee 8 active Intraday picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 1 Oct, 3:23 pm IST
3 supporting0 opposing
Supports the BUY call (3)

Emcure Pharmaceuticals Limited (NSE: EMCURE) Reveals Strong Revenue Growth in FY26 Presentation

NewsGoogle News·28 Sept · 2d ago

(opens in new tab)

Emcure Pharmaceuticals reports over $1 billion operating revenue in FY26 with 16.6% growth

NewsGoogle News·25 Sept · 5d ago

(opens in new tab)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·18 Sept · 2w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.